Encyclopedia

  • ArticleSelf Resistance to the Atypical Cationic Antimicrobial Peptide Edeine (cas 11006-90-9) of Brevibacillus brevis Vm4 by the N-Acetyltransferase EdeQ
  • Add time:08/14/2019         Source:sciencedirect.com

    SummaryEdeine (cas 11006-90-9)s are atypical cationic peptides produced by Brevibacillus brevis Vm4 with broad-spectrum antimicrobial activity. These linear nonribosomal peptides bind to the 30S ribosomal subunit and block t-RNA binding to the P-site. To identify the mechanism of high-level self-resistance in the producing organism, the B. brevis Vm4 genome was sequenced and the edeine biosynthetic cluster discovered. A potential edeine-modifying enzyme, EdeQ, showed similarity to spermidine N-acetyltransferases. EdeQ was purified and shown to convert edeine to N-acetyledeine, which is inactive against cells in vivo and against cell-free extracts. Unexpectedly, tandem mass spectroscopy and nuclear magnetic resonance demonstrate that N-acylation occurs on the free amine of the internal diaminopropionic acid rather than the N-terminal spermidine polyamine. Acetylation of edeine by EdeQ abolishes its ability to inhibit translation, thus conferring resistance to the antibiotic in the producing organism.

    We also recommend Trading Suppliers and Manufacturers of Edeine (cas 11006-90-9). Pls Click Website Link as below: cas 11006-90-9 suppliers


    Prev:Synthesis and structure determination of some derivatives of the antibiotic thermorubin (cas 11006-83-0)
    Next: ArticleDissecting the Ribosomal Inhibition Mechanisms of Edeine (cas 11006-90-9) and Pactamycin: The Universally Conserved Residues G693 and C795 Regulate P-Site RNA Binding)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View